Holen Sie sich die Stockscreener-App
22.17
0.18%
0.04
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$22.13
Offen:
$22.28
24-Stunden-Volumen:
620.73K
Relative Volume:
0.52
Marktkapitalisierung:
$11.80B
Einnahmen:
$22.44B
Nettoeinkommen (Verlust:
$1.35B
KGV:
11.67
EPS:
1.9002
Netto-Cashflow:
$2.03B
1W Leistung:
+5.27%
1M Leistung:
-3.48%
6M Leistung:
-2.64%
1J Leistung:
-18.01%
1-Tages-Spanne:
$22.11
$22.38
1-Wochen-Bereich:
$21.05
$22.38
52-Wochen-Spanne:
$20.02
$27.43
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Firmenname
Fresenius Medical Care Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare FMS vs HCA, THC, EHC, DVA
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
22.17 | 11.80B | 22.44B | 1.35B | 2.03B | 1.9002 |
HCA
Hca Healthcare Inc
|
458.84 | 99.34B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
267.25 | 21.52B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
127.87 | 12.61B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
187.31 | 11.95B | 13.84B | 1.10B | 1.49B | 10.42 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-29 | Herabstufung | Berenberg | Buy → Hold |
| 2026-07-28 | Herabstufung | BNP Paribas Exane | Neutral → Underperform |
| 2026-07-16 | Eingeleitet | Bernstein | Mkt Perform |
| 2026-01-20 | Herabstufung | Goldman | Buy → Neutral |
| 2025-10-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-09-02 | Herabstufung | UBS | Neutral → Sell |
| 2024-12-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-11-06 | Eingeleitet | Berenberg | Buy |
| 2024-01-08 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-17 | Hochstufung | Societe Generale | Hold → Buy |
| 2023-08-14 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-01 | Fortgesetzt | Citigroup | Neutral |
| 2023-07-12 | Eingeleitet | Goldman | Buy |
| 2023-03-07 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-01-03 | Herabstufung | Jefferies | Buy → Underperform |
| 2022-10-26 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2022-10-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-27 | Hochstufung | Jefferies | Underperform → Buy |
| 2022-02-11 | Herabstufung | Jefferies | Hold → Underperform |
| 2021-11-23 | Eingeleitet | HSBC Securities | Hold |
| 2021-11-11 | Hochstufung | Jefferies | Underperform → Hold |
| 2021-02-04 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-08-05 | Herabstufung | Jefferies | Buy → Hold |
| 2020-05-20 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | Hochstufung | Jefferies | Hold → Buy |
| 2019-06-20 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-12-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | Hochstufung | UBS | Neutral → Buy |
| 2018-08-28 | Hochstufung | HSBC Securities | Hold → Buy |
| 2018-07-05 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | Hochstufung | UBS | Sell → Neutral |
| 2017-12-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | Hochstufung | Citigroup | Neutral → Buy |
| 2016-07-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2016-01-04 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2015-11-04 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | Hochstufung | Goldman | Neutral → Buy |
| 2015-08-13 | Herabstufung | Societe Generale | Buy → Hold |
| 2015-07-31 | Bestätigt | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | Bestätigt | Feltl & Co. | Hold |
| 2013-01-14 | Hochstufung | HSBC Securities | Neutral → Overweight |
Alle ansehen
Fresenius Medical Care Ag Adr Aktie (FMS) Neueste Nachrichten
MWB Research Upgrades Fresenius Medical Care to Buy, Lifts PT - www.marketscreener.com
Fresenius Medical Care AG: Dividend historical data and projections - www.marketscreener.com
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Gets Price Target Cut from Truist Financial - MarketBeat
Futures Contracts for Fresenius Medical Care AG Futures - TradingView
Fresenius Medical Care AG (FME) Buys 1.031M Shares Oct 5–9 - TradingView
Fresenius Medical Care AG : Release of a capital market information - TradingView
Fresenius Medical Care AG (FME) Repurchases 1.031M Shares - TradingView
Fresenius Medical Care AG Futures Price Chart — EUREX:FMEHG2017 - TradingView
Fresenius Medical Care AG : Bernstein reiterates its Neutral rating - www.marketscreener.com
Fresenius Medical Care replaces CEO, stock under pressure - marketscreener.com
Fresenius Medical Care: CEO Change Brings Out Market Bears - Morningstar
Fresenius Medical Care AG (FMS) Shares Fall 7.7% -- What GF Scor - GuruFocus
Fresenius Medical Care AG Stock (FMS) Moved Down by 7.45% on Oct 7: What Investors Need To Know - TradingKey
Fresenius Medical Care AG : JP Morgan remains a Sell rating - www.marketscreener.com
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - TradingView
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Yahoo Finance
Fresenius Medical Care tumbles on CEO transition announcement - Investing.com
Fresenius Medical Care (FMS) Names Shervin Korangy as New CEO an - GuruFocus
Shervin J. Korangy appointed CEO of Fresenius Medical Care to lead the next phase of strategic development and long-term profitable growth - Fresenius Medical Care
Fresenius Medical Care AG : Change in CEO – Shervin J. Korangy Succeeds Helen Giza - www.marketscreener.com
Fresenius Medical Care: Margin Expansion Supports The Story, But Growth Remains Limited - Seeking Alpha
XS2084488209 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG (FME.DE) Stock Price, News, Quote & History - ca.finance.yahoo.com
Turning experience into impact: Vanessa Evans’ journey through kidney disease - Fresenius Medical Care
XS323349908 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care AG : Goldman Sachs remains Neutral - marketscreener.com
Fresenius Medical Care AG (FMS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Rating Lowered by Berenberg Bank - MarketBeat
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - TradingView
Fresenius Medical Care Reshapes China Portfolio for Long-Term Growth - Yahoo Finance
Fresenius Medical Care AG & Co KGaA Accelerating Growth in Home Dialysis Call Transcript - GuruFocus
Fresenius Medical Care AG : Berenberg is Neutral - marketscreener.com
Fresenius Medical Care stock at EUR 40.44 on September 28, 2026 - ad-hoc-news.de
Fresenius Medical Care AG (FME) Reports Goldman Sachs Voting Rights Notification - TradingView
Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - TradingView
Fresenius Medical Care AG : Release of a capital market information - marketscreener.com
Fresenius Medical Care AG (FME) Updates Share Buyback - TradingView
Fresenius Medical Care AG (FME) Updates Share Buyback Totals - TradingView
Weekly Recap: China strategy shift and €110M one-time Q3 2026 charges - TradingView
XS3036647777 Bond Profile: Coupon and Redemption - TradingView
Fresenius Medical Care Refines China Strategy With Targeted Product Focus - Benzinga
Fresenius Medical Care Plans to Exit China Peritoneal Dialysis Business - finance.yahoo.com
A planned dialysis business exit in China carries expected one-time costs for Fresenius Medical Care (FMS). - Stock Titan
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Stock Has Consensus Price Target of $23.57 According to Brokerages - MarketBeat
Strategic shift in China costs Fresenius Medical Care €110m - marketscreener.com
Fresenius Medical Care Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership - Fresenius Medical Care
Hackers attack dialysis group Fresenius Medical Care - marketscreener.com
Fresenius Medical Care stock falls 0.8 percent ahead of the open - AD HOC NEWS
Finanzdaten der Fresenius Medical Care Ag Adr-Aktie (FMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):